“Getting Their Attention: Streamlining Patient Education” With Margaret Highley, MSN, RN, OCN®, and Rebecca Grimmett, RN, OCN®

Patient education regarding the purpose and side effects of medications can be important to ensuring adherence and optimizing patient outcomes. However, it can be difficult for patients to absorb this information while experiencing an episode of acute illness, especially given the anxiety that can accompany a frightening diagnosis such as cancer. Margaret Highley, MSN, RN, OCN®, and members of the surgical oncology unit at The James Cancer Hospital and Solove Research Institute at The Ohio State...
Continue reading

Telerehabilitation Helps Patients With Advanced Cancer

​ According to a new study, telerehabilitation can help patients with advanced cancer by improving function and decreasing pain, length of hospital stay, and requirements for postacute care. Patients with advanced cancer can experience disabling losses of function that impact their quality of life and increase their use of health care services. In addition, impaired mobility can increase the frequency and length of hospital stays. Rehabilitation services and conditioning activities can help to r...
Continue reading

Pegfilgrastim Biosimilar One Step Closer to FDA Approval

The pharmaceutical company Sandoz recently resubmitted its Biologics License Application to the FDA for a proposed pegfilgrastim biosimilar. Pegfilgrastim is a granulocyte colony-stimulating factor (G-CSF) used to treat neutropenia, a side effect of chemotherapy that kills 4,000 cancer patients every year in the United States. A biosimilar is a drug made up of living organisms that is "similar" to another biologic medicine (considered to be the reference product) that is already FDA approved. A ...
Continue reading

Caring for Older Patients With Advanced Cancers Affects Caregivers’ Emotional Health

For many informal caregivers, providing assistance to loved ones with cancer is emotionally taxing, especially for those taking care of older patients with advanced cancers. Researchers set out to better understand the relationship between older patients with cancer and their caregivers' mental health and quality of life (QOL) and found that caring for older patients with advanced cancers negatively impacts caregivers' emotional health. In a clinical trial, published in the Journal of the Americ...
Continue reading

Avoiding Trastuzumab’s Cardiotoxic Effects in Breast Cancer

​ Molecular targeted therapies such as trastuzumab, which targets the human epidermal growth factor receptor 2 (HER2), significantly improve outcomes for patients with cancer. However, these medications—particularly trastuzumab—can also result in cardiovascular side effects. Researchers at the Stanford University School of Medicine have identified a key mechanism underlying trastuzumab-induced cardiac dysfunction in patients with HER2-positive breast cancer. In addition, they have found an exist...
Continue reading

© Copyright 2019 i3 Health. All rights reserved.